相关实验视频
Updated: May 28, 2025

10:19
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
14.2K
怀孕和哺乳期个体对新型B组链球菌疫苗的看法
Monica Sosa1, Candace Haghighi2, Mindy Pike1
1From the Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington.
The Pediatric infectious disease journal
|February 14, 2025
概括
在怀孕期间,新型B组菌 (GBS) 疫苗临床试验的可接受性是混合的,但在哺乳期更高. 大多数参与者更喜欢基于蛋白质或mRNA的疫苗平台.
科学领域:
- 产科和妇科 产科和妇科
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 针对B组链球菌 (GBS) 的多价值合疫苗正在开发中,用于母体免疫.
- 了解孕妇和哺乳期患者对新型GBS疫苗的看法至关重要,特别是在COVID-19疫苗经验之后.
研究的目的:
- 评估怀孕和哺乳期患者对新型GBS疫苗临床试验参与的知识和可接受性.
- 在这些人群中探索GBS疫苗平台的偏好.
主要方法:
- 在正在进行的基于调查的前性队列研究中,对参与者进行了后续调查.
- 该调查包括关于GBS知识和愿意参加GBS疫苗临床试验的问题.
- 通过REDCap在线收集了14903名参与者的数据.
主要成果:
- 与非孕妇/哺乳期患者相比,孕妇在怀孕期间参加GBS疫苗试验的可能性较低 (P < 0.001).
- 与非孕妇/哺乳期患者相比,哺乳期患者在哺乳期更有可能参加GBS疫苗试验 (P < 0.001).
- 首选的疫苗平台包括基于蛋白质 (70.5%) 和基于mRNA (71.5%) 的技术.
结论:
- 参与者表现出对GBS有很好的理解.
- 怀孕期间新型GBS疫苗试验的可接受性是混合的,但在哺乳期更高.
- 孕妇和哺乳期患者的观点对于开发新的GBS疫苗至关重要.
相关概念视频
Development of Immunocompetence
282
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
282
Vaccinations
43.8K
Overview
43.8K

